lithium investing Critical Elements Announces Positive Feasibility Study with a Pre-Tax NPV 8% of $1.257 B and a Pre-Tax IRR of 48.2% for Its Rose Lithium Project
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
Heliostar Reports 52.4m Grading 5.84 g/t Gold from the High Grade Panel and Continues to Build Out the Expansion Zone at Ana Paula
Precious Metals & Critical Minerals Virtual Investor Conference Presentations Now Available for On-Demand Viewing
